White House urges RSV vaccine makers to meet demand
White House urges RSV vaccine makers to meet demand
US FDA approves Pfizer's maternal RSV vaccine to protect infants
US FDA approves Pfizer's maternal RSV vaccine to protect infants
US CDC panel recommends Sanofi-AstraZeneca's preventive RSV therapy for babies
US CDC panel recommends Sanofi-AstraZeneca's preventive RSV therapy for babies
EU health regulator backs Pfizer's RSV vaccine for infants, older adults
EU health regulator backs Pfizer's RSV vaccine for infants, older adults
US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies
US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSV
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSV
GSK's RSV vaccine shows long-term efficacy in late-stage trial
GSK's RSV vaccine shows long-term efficacy in late-stage trial
EU approves its first vaccine for common respiratory virus RSV
EU approves its first vaccine for common respiratory virus RSV
U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
Pfizer's maternal RSV vaccine effective at preventing severe infections in newborns, FDA says but flags potential risk of preterm birth
Pfizer's maternal RSV vaccine effective at preventing severe infections in newborns, FDA says but flags potential risk of preterm birth